H.C. Wainwright lowered the firm’s price target on Vigil Neuroscience (VIGL) to $14 from $17 and keeps a Buy rating on the shares ahead of ...

A total of 25 investors have a majority stake in the company with 38% ownership Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock If ...

The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can ...

Full Year 2024 Results Key Financial Results Revenue: CHF20.2m (flat on FY 2023). Net ...

Financially, Monopar has a cash runway until 2026 but will need additional funds for commercialization efforts. See why I'm ...

During three years of share price growth, Cosmo Pharmaceuticals moved from a loss to profitability. That would generally be considered a positive, so we'd expect the share price to be up. You can see ...

Full Year 2024 Results Key Financial Results Revenue: CHF719.6m (down ...

Full Year 2024 Results Key Financial Results Revenue: CHF590.6m (up 14% from FY 2023).

ROME, Feb. 28 (Xinhua) -- Italy's consumer prices rose by 1.7 percent year-on-year in February ... the Italian government on Friday unveiled a 3-billion-euro (3.1 billion U.S. dollars) package ...

Full Year 2024 Results Key Financial Results Revenue: CHF374.4m (flat on FY 2023).

Its average revenue per user (or ARPU) is holding steady at just above $41 per year, after a slight-but-expected lull from 2022's pandemic-prompted peak. Data source: Roku Inc. Chart by author.